Development of selected coagulation factors and anticoagulants in preterm infants by the age of six months

Thrombosis and Haemostasis

Volumn 92, Issue 4, 2004, Pages 688-696

  Salonvaara, Marjut ^a   Riikonen, Pekka ^a   Vahtera, Elina ^b   Mahlamäki, Eija ^a   Heinonen, Kirsti ^a   Kekomäki, Riitta ^b  

^a KUOPIO UNIVERSITY HOSPITAL   (Finland)

^b FINNISH RED CROSS BLOOD SERVICE   (Finland)

Author keywords

Coagulation factor; Development; Infant; Physiological anticoagulant; Prematurity

Indexed keywords

ANTICOAGULANT PROTEIN; ANTITHROMBIN; BLOOD CLOTTING FACTOR; BLOOD CLOTTING FACTOR 10; BLOOD CLOTTING FACTOR 5; BLOOD CLOTTING FACTOR 5 LEIDEN; BLOOD CLOTTING FACTOR 7; DNA; PROTEIN C; PROTEIN S; PROTHROMBIN;

AGE; ARTICLE; BIRTH WEIGHT; BLEEDING; CHILDBIRTH; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORRELATION ANALYSIS; DNA DETERMINATION; FEMALE; FOLLOW UP; GESTATIONAL AGE; HEMOSTASIS; HUMAN; MAJOR CLINICAL STUDY; MALE; NEWBORN; PREMATURITY; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; VERY LOW BIRTH WEIGHT;

AGE FACTORS; BLOOD COAGULATION FACTOR INHIBITORS; BLOOD COAGULATION FACTORS; FEMALE; GESTATIONAL AGE; HEMOSTASIS; HUMANS; INFANT; INFANT, NEWBORN; INFANT, PREMATURE; MALE;

EID: 6344226749     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH03-12-0769     Document Type: Article

References (23)

1. Hathaway WE. The bleeding newborn. Semin Hematol 1975; 12: 175-88
2. Andrew M, Paes B, Milner R, et al. Development of the human coagulation system in the healthy premature infant. Blood 1988; 72: 1651-57
3. Andrew M, Paes B, Milner R, et al. Development of the human coagulation system in the healthy full-term infant. Blood 1987; 70: 165-72
4. Piecuch RE, Leonard CH, Cooper BA, et al. Outcome of extremely low birth weight infants (500 to 999 grams) over a 12-year period. Pediatrics, 1997; 100; 633-9
5. Forestier F, Daffos E Galactéros F, et al. Hematological values of 163 normal fetuses between 18 and 30 weeks of gestation. Pediatr Res 1986; 20: 342-6
6. Reverdiau-Moalic P, Delahousse B, Body G, et al. Evolution of blood coagulation activators and inhibitors in the healthy human fetus. Blood 1996; 88: 900-6.
7. Barnard D, Simmons M, Hathaway W. Coagulation studies in extremely premature infants. Pediatr Res 1979; 13: 1330-5
8. Shankaran S, Bauer CR, Bain R, et al. Prenatal and perinatal risk and protective factors for neonatal intracranial hemorrhage. Arch Pediatr Adolesc Med 1996; 150: 491-7
9. Mautone A, Girdano P, Montagna O, et al. Coagulation and fibrinolytic systems in the ill preterm newborn. Acta Paediatr 1997; 86: 1100-4.
10. Puckett RM, Offringa M. Prophylactic vitamin K for vitamin K deficiency bleeding in neonates (Cochrane Review). In: The Cochrane Library, Issue 1 2003; Oxford: Update Software.
11. Crowther CA, Henderson-Smart DJ. Vitamin K prior to preterm birth for preventing neonatal periventricular haemorrhage (Cochrane Review). In: The Cochrane Library, Issue 1 2001; Oxford : Update Software.
12. Salonvaara M, Riikonen P, Kekomäiki R, et al. Effects of gestational age and pre-and perinatal events on the coagulation status in premature infants. Arch Dis Child Fetal Ed 2003; 88: F324-F328.
13. Williams MD, Chalmers EA, Gibson BE. Guideline. The investigation and management of neonatal haemostasis and thrombosis. Br J Haematol 2002; 119: 295-309.
14. Kuhle S, Male C, Mitchell L. Developmental hemostasis: pro-and anticoagulant systems during childhood. Semin Thromb Hemost 2003; 29: 329-37.
15. Kühne T, Imbach P. Neonatal platelet physiology and patophysiology. Eur J Pediatr 1998; 157: 87-94.
16. Mann KG, Kalafatis M. Factor V: a combination of Dr Jekyll and Mr Hyde. Blood 2003; 101: 20-30.
17. Van Hylckama Vlieg A, Callas PW, Cushman M, et al. Inter-relation of coagulation factors and D-dimer levels in healthy individuals. J Thromb Haemost 2003; 1: 516-22.
18. Nicolaes GAF, Dahlbäck B. Factor V and thrombotic disease. Description of a Janus-Faced Protein. Arterioscl Thromb Vasc Biol 2002; 22: 530-8.
19. Fair DS, Marlar RA. Biosynthesis and secretion of factor VII, protein C, protein S, and the protein C inhibitor from a human hepatoma cell line. Blood 1986; 67: 64-70.
20. Andrew M, Vegh P, Johnston M, et al. Maturation of the hemostatic system during childhood. Blood 1992; 80: 1998-2005.
21. Malm J, Bennhagen R, Holmberg L, et al. Plasma concentrations of C4b-binding protein and vitamin K-dependent protein S in term and preterm infants: low levels of protein S-C4b-binding protein complexes. Br J Haematol 1988; 68: 445-9.
22. Sthoeger D, Nardi M, Karpatkin M. Protein S in the first year of life. Br J Haematol 1989; 72: 424-8.
23. Garcia de Frutos P, Mohammed Alim RI, Härdig Y, et al. Differential regulation of a and β chains of C4b-binding protein during acute-phase response resulting in stable plasma levels of free anticoagulant protein S. Blood 1994; 84: 815-22.